SCHEMBL3859779

SCHEMBL3859779

CC(C)(CN)OC(=O)C1CCNCC1.COC(=O)C(CO)NC(=O)NC1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.44
EPHX2 P34913 3/20 0.38
NPSR1 Q6W5P4 5/20 0.38
ALDH1A1 P00352 5/20 0.38
MAPT P10636 5/20 0.38
MAPK1 P28482 5/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
POLB P06746 4/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
GPR55 Q9Y2T6 1/20 0.36
YAP1 P46937 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
NTSR1 P30989 1/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
NPC1 O15118 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3249206 0.85 EPHX1 (0.60) EPHX1EPHX2NPSR1ALDH1A1MAPT
SCHEMBL3249205 0.85 EPHX1 (0.60) EPHX1EPHX2NPSR1ALDH1A1MAPT
SCHEMBL27693908 0.76 EPHX1 (0.61) EPHX1EPHX2NPSR1ALDH1A1MAPT
SCHEMBL27693907 0.76 EPHX1 (0.61) EPHX1EPHX2NPSR1ALDH1A1MAPT
SCHEMBL2585461 0.74 PTPN2 (0.49) EPHX1MAPK1MEN1KMT2AYAP1
SCHEMBL7501015 0.73 MAPT (0.42) ALDH1A1MAPTMAPK1L3MBTL1NPC1
SCHEMBL14497217 0.70 EPHX1 (0.58) EPHX1EPHX2ALDH1A1MAPTMAPK1
SCHEMBL3248423 0.70 EPHX1 (0.61) EPHX1EPHX2NPSR1ALDH1A1MAPT
SCHEMBL3248424 0.70 EPHX1 (0.61) EPHX1EPHX2NPSR1ALDH1A1MAPT
SCHEMBL363474 0.69 GABRP (0.41) EPHX1EPHX2ALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1856100-A4 CGRP RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2009-04-15 EP disclosed
EP-1856100-A2 CGRP RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2007-11-21 EP disclosed
WO-2006078554-A2 CGRP RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2006-07-27 WO disclosed